Top Tweets for #USFDa

2 days ago

.@ZydusUniverse has received the Establishment Inspection Report (EIR) from @US_FDA for its injectable manufacturing facility located at Zydus Biotech Park, Ahmedabad. Read: https://t.co/sNCgVPJm5C #pharma #EIR #USFDA

0

97

Lupin

@LupinGlobal

2 days ago

Lupin received approval under the Federal Food, Drug, and Cosmetic Act (FD&C Act) for its Abbreviated New Drug Application for Diazepam Injection USP, 10 mg/2 mL (5 mg/mL), Single-Dose Prefilled Syringes. Read More: https://t.co/ddffHFQCLK #LupinInNews #USFDA #PharmaInnovation #HealthcareInnovation #PR #Lupin

LupinGlobal's tweet photo. Lupin received approval under the Federal Food, Drug, and Cosmetic Act (FD&C Act) for its Abbreviated New Drug Application for Diazepam Injection USP, 10 mg/2 mL (5 mg/mL), Single-Dose Prefilled Syringes.
Read More: https://t.co/ddffHFQCLK

#LupinInNews #USFDA #PharmaInnovation #HealthcareInnovation #PR #Lupin

1

2

1

0

307

4 days ago

Lupin gets FDA nod for launch of Generic Sugammadex injection in US market https://t.co/k10PNzdk3r #Sugammadex #Lupin #USFDA @indpharmapost

0

1

0

80

4 days ago

Lupin launches generic Sugammadex Injection in the US following FDA approval https://t.co/UPHLnacmI6 #Sugammadex #Lupin #USFDA @indpharmapost

0

77

4 days ago

Dr Reddy’s gets #USFDA approval for rituximab biosimilar, expanding its biosimilars footprint in the US market. Fresenius Kabi to exclusively commercialise the product in the US. #Pharma @anshul91_m https://t.co/ecFZWw8Ri7

CNBCTV18News's tweet photo. Dr Reddy’s gets #USFDA approval for rituximab biosimilar, expanding its biosimilars footprint in the US market.

Fresenius Kabi to exclusively commercialise the product in the US.

#Pharma @anshul91_m

https://t.co/ecFZWw8Ri7 https://t.co/vtAnR71K1v

0

1

0

5K

4 days ago

Dr Reddy’s gets #USFDA approval for rituximab biosimilar, expanding its biosimilars footprint in the US market. Fresenius Kabi to exclusively commercialise the product in the US. #Pharma https://t.co/ecFZWw8Ri7

0

2

0

5K

@CNBCTV18Live

4 days ago

#JustIn | #DrReddy'sLabs Receives #USFDA Approval For #Rituximab Biosimilar 🚨Alert: Rituximab Is Used To Treat Chronic Leukemia & Some Auto-immune Conditions

CNBCTV18Live's tweet photo. #JustIn | #DrReddy'sLabs Receives #USFDA Approval For #Rituximab Biosimilar

🚨Alert: Rituximab Is Used To Treat Chronic Leukemia & Some Auto-immune Conditions https://t.co/SSEqPLFxJz

0

25

2

1

24K

ET NOW

@ETNOWlive

4 days ago

#StockInNews | Dr Reddy's Laboratories receives US FDA approval for its rituximab biosimilar for the U.S. market. The therapy is used to treat blood cancers and autoimmune diseases. #DrReddys #USFDA #Pharma #Healthcare #Biotech

ETNOWlive's tweet photo. #StockInNews | Dr Reddy's Laboratories receives US FDA approval for its rituximab biosimilar for the U.S. market. The therapy is used to treat blood cancers and autoimmune diseases.

#DrReddys #USFDA #Pharma #Healthcare #Biotech https://t.co/GYNI0OMgjL

1

8

0

1

7K

Capital Market Publishers India Pvt. Ltd. @CapitalMarket17

5 days ago

#Lupin gets #USFDA approval for #Diazepam injection targeting $78 million US market @jpullokaran https://t.co/ICWnKNS2Fx

0

17

3

1

10K

Karan Shah @karanshah137

5 days ago

Another underrated catalyst? Transdermal patches. ✅ First EU launch expected soon. ✅ First USFDA transdermal submission already completed. New dosage formats often create far less crowded markets than traditional generics. #USFDA #Pharma

1

0

34

5 days ago

Lupin Expands US Portfolio with FDA-Approved Generic Sugammadex Injection Launch https://t.co/wyCgzDyy3W #LupinPharma #PharmaNews #USFDA #GenericDrugs #Sugammadex #Bridion #Pharmaceuticals #USMarket #HealthcareIndustry #ComplexGenerics #Injectables #PharmaIndustry #StockMarket

CapitalMarket17's tweet photo. Lupin Expands US Portfolio with FDA-Approved Generic Sugammadex Injection Launch
https://t.co/wyCgzDyy3W
#LupinPharma #PharmaNews #USFDA #GenericDrugs #Sugammadex #Bridion #Pharmaceuticals #USMarket #HealthcareIndustry #ComplexGenerics #Injectables #PharmaIndustry #StockMarket https://t.co/DvLvoW0nW2

0

1

0

173

Lupin

@LupinGlobal

5 days ago

Lupin announced U.S. FDA approval for its Abbreviated New Drug Application and launch of Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vial in the United States. Read More: https://t.co/Z7QcUodh9O #LupinInNews #USFDA #PharmaceuticalExcellence #GlobalHealthcare #QualityMedicines #Lupin

LupinGlobal's tweet photo. Lupin announced U.S. FDA approval for its Abbreviated New Drug Application and launch of Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vial in the United States.

Read More: https://t.co/Z7QcUodh9O

#LupinInNews #USFDA #PharmaceuticalExcellence #GlobalHealthcare #QualityMedicines #Lupin

0

305

Saptashwa TV

@SaptashwaTV

5 days ago

Lupin Launches Generic Sugammadex Injection in US, Strengthening Hospital Drug Portfolio https://t.co/YpZZ5zCWgn #Lupin #Sugammadex #USFDA #GenericMedicine #Pharma

0

29

5 days ago

#Lupin shares gain after #USFDA nod, launch of generic Sugammadex Injection for neuromuscular blockade reversal @GareemaBangad https://t.co/mSDOApNtjh

0

1

0

4K

ExpPharma @ExpPharma

5 days ago

#Lupin announces #USFDA approval and launch of Sugammadex injection - https://t.co/lC3MjWXOgi | #pharma #pharmanews #healthtech #pharmatech

0

221

ET NOW

@ETNOWlive

5 days ago

#StockInNews | Lupin receives US FDA approval and launches Sugammadex Injection, a medication used to reverse the effects of muscle relaxants and restore muscle function after anesthesia #Lupin #USFDA #Pharma

ETNOWlive's tweet photo. #StockInNews | Lupin receives US FDA approval and launches Sugammadex Injection, a medication used to reverse the effects of muscle relaxants and restore muscle function after anesthesia

#Lupin #USFDA #Pharma https://t.co/p7IHQgNVdi

1

2

0

6K